IP Library Granted Patent US 9,849,237
Granted Patent B2
US 9,849,237 · App. 14/232,305 · Granted Dec 26, 2017

Injection system with capacitive sensing

Inventors: Chad M. Gibson (Westerville, OH); Charles S. Neer (Cincinnati, OH)
Assignee: LIEBEL-FLARSHEIM COMPANY LLC
A61M5/16809A61M5/14546A61M5/16831A61M5/14566A61M2005/14553A61M2205/3317A61M2205/3389
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,849,237
App. No.
14/232,305
Granted
Dec 26, 2017
Kind
B2
Abstract

A powerhead ( 50 ) of a power injector is disclosed that includes a syringe housing ( 110 ) that contains a capacitive fluid detector ( 112 ). The capacitive fluid detector ( 112 ) may be operable to detect fluid within a syringe ( 116 ) installed on the syringe housing ( 110 ). The output of the capacitive fluid detector ( 112 ) may be used to estimate the volume of fluid within the syringe ( 116 ). The capacitive fluid detector ( 112 ) may include a plurality of discrete capacitors ( 118 a - 118 h ) arranged serially along a longitudinal axis ( 120 ) of the syringe ( 116 ). Each of the plurality of capacitors ( 118 a - 118 h ) may be operable to produce an electric field extending into the syringe ( 116 ). Each of the plurality of capacitors ( 118 a - 118 h ) may be formed on a printed circuit board ( 130 ).

Claims (21)

1. An injection system comprising:

an injection device comprising a powerhead and a syringe housing, wherein said syringe housing comprises a cradle that extends away from said powerhead;

a syringe mounted to said injection device, wherein said syringe housing provides an interface between said powerhead and said syringe, wherein said injection device is operable to discharge fluid from said syringe, wherein said syringe comprises a syringe barrel, wherein said syringe barrel has a syringe barrel length along a syringe barrel longitudinal axis, wherein said cradle of said syringe housing extends along said syringe barrel, and wherein said syringe extends above said cradle;

a capacitive fluid detector disposed along said syringe barrel and enclosed within said cradle of said syringe housing such that said cradle of said syringe housing is disposed between said capacitive fluid detector and said syringe, wherein said capacitive fluid detector comprises a plurality of capacitors, wherein said plurality of capacitors are arranged serially along said syringe barrel length and are spaced from one another along said syringe barrel length, wherein each of said plurality of capacitors is disposed at a different position along said syringe barrel longitudinal axis;

a syringe barrel zone coextensive with said syringe barrel, wherein said syringe barrel zone comprises a syringe barrel zone length coinciding with said syringe barrel length; wherein said syringe barrel zone comprises a syringe barrel zone longitudinal axis coinciding with said syringe barrel longitudinal axis; and

a fluid level determination logic operable to determine a level of a fluid within said syringe barrel zone at least partially based on an output from each capacitor of said plurality of capacitors;

wherein said fluid level determination logic determines whether each said output is either of a first capacitance level or a second capacitance level, with said first capacitance level being associated with a presence of fluid and with said second capacitance level being associated with an absence of fluid; and

wherein said fluid level determination logic uses the determination of each said capacitor of said plurality of capacitors either being of said first capacitance level or said second capacitance level to calculate an estimated volume of said fluid in said syringe.

2. The injection system of claim 1 , wherein said plurality of capacitors arranged serially along said syringe barrel zone length comprises at least eight individual said capacitors.

3. The injection system of claim 1 , wherein each capacitor of said plurality of capacitors comprises a pair of electrodes, wherein each electrode of each pair of electrodes is arranged such that a vector perpendicular to and intersecting said electrode does not intersect any other electrode.

4. The injection system of claim 3 , wherein each electrode of said pair of electrodes comprises two substantially coplanar electrodes.

5. The injection system of claim 1 , wherein each capacitor of said plurality of capacitors is interconnected to an integrated circuit, wherein for each of said plurality of capacitors, said integrated circuit is operable to produce a bimodal output, wherein a first mode of said bimodal output is in response to a presence of said fluid and a second mode of said bimodal output is in response to a lack of said fluid.

6. The injection system of claim 1 , wherein each capacitor of said plurality of capacitors is operable to produce an analog output that varies in response to an amount of fluid within an electric field of said capacitor.

7. The injection system of claim 1 , further comprising a user input determination logic operable to determine a user input at least partially based on output from said capacitive fluid detector.

8. The injection system of claim 1 , further comprising a capacitive user input detector, wherein an electric field of said capacitive user input detector penetrates said syringe barrel zone within a first region that extends along said syringe barrel zone.

9. The injection system of claim 8 , wherein said electric field of said capacitive user input detector penetrates said syringe barrel zone within a second region that extends along said syringe barrel zone, wherein said second region is on an opposite side of said syringe barrel zone than said first region.

10. The injection system of claim 8 , further comprising a user input determination logic operable to determine a user input at least partially based on output from said capacitive user input detector.

11. The injection system of claim 1 , wherein said injection system is operable to detect a presence of a finger of a user adjacent to said syringe barrel zone.

12. The injection system of claim 1 , wherein said injection system is operable to detect a movement of a finger of a user adjacent to said syringe barrel zone.

13. The injection system of claim 1 , wherein said syringe housing comprises a faceplate that is installed on the powerhead, and wherein said cradle extends away from said faceplate.

14. The injection system of claim 1 , wherein said capacitive fluid detector comprises a printed circuit board (PCB), wherein the plurality of capacitors are disposed on the PCB, and wherein the PCB and plurality of capacitors are sealed within said syringe housing.

Assignments (5)
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 032480, FRAME 0001 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: THERAKOS, INC.; MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065609/0322 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 13, 2017
From: MALLINCKRODT LLC
To: LIEBEL-FLARSHEIM COMPANY LLC
Reel/Frame 043845/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 26, 2016
From: GIBSON, CHAD M.; NEER, CHARLES S.
To: MALLINCKRODT LLC
Reel/Frame 039853/0891 →
RELEASE OF SECURITY INTEREST Recorded Nov 30, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: LIEBEL-FLARSHEIM COMPANY LLC
Reel/Frame 037172/0094 →
SECURITY INTEREST Recorded Mar 19, 2014
From: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS INC.; MALLINCKRODT CARIBBEAN, INC.; MALLINCKRODT US POOL LLC; MALLINCKRODT INC.; LUDLOW CORPORATION; CNS THERAPEUTICS, INC.; ENTERPRISES HOLDINGS, INC.; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS, INC; MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC; MALLINCKRODT ENTERPRISES HOLDINGS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 032480/0001 →
Continuity (2)
Provisional Application 61508734 · Jul 18, 2011
Related Publication 20140142537A1 · May 22, 2014